JPH04287688A - 繊維芽細胞増殖因子の活性フラグメント - Google Patents

繊維芽細胞増殖因子の活性フラグメント

Info

Publication number
JPH04287688A
JPH04287688A JP3331577A JP33157791A JPH04287688A JP H04287688 A JPH04287688 A JP H04287688A JP 3331577 A JP3331577 A JP 3331577A JP 33157791 A JP33157791 A JP 33157791A JP H04287688 A JPH04287688 A JP H04287688A
Authority
JP
Japan
Prior art keywords
bfgf
heparin
fragment
growth factor
fibroblast growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3331577A
Other languages
English (en)
Japanese (ja)
Inventor
Andrew P Seddon
アンドリユー・ピー・セツドン
Peter Bohlen
ピーター・ボーレン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of JPH04287688A publication Critical patent/JPH04287688A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP3331577A 1990-11-23 1991-11-21 繊維芽細胞増殖因子の活性フラグメント Pending JPH04287688A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US615207 1990-11-23
US07/615,207 US5206354A (en) 1990-11-23 1990-11-23 Dna sequence encoding active fragment of fibroblast growth factor, hbf-2

Publications (1)

Publication Number Publication Date
JPH04287688A true JPH04287688A (ja) 1992-10-13

Family

ID=24464445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3331577A Pending JPH04287688A (ja) 1990-11-23 1991-11-21 繊維芽細胞増殖因子の活性フラグメント

Country Status (12)

Country Link
US (2) US5206354A (enExample)
EP (1) EP0486861A1 (enExample)
JP (1) JPH04287688A (enExample)
KR (1) KR920009849A (enExample)
AU (1) AU647547B2 (enExample)
CA (1) CA2055961A1 (enExample)
IE (1) IE914067A1 (enExample)
IL (1) IL99985A0 (enExample)
NZ (1) NZ240623A (enExample)
PT (1) PT99566A (enExample)
TW (1) TW211585B (enExample)
ZA (1) ZA919259B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459250A (en) * 1987-06-16 1995-10-17 New York University Truncated mammalian growth factor DNA sequence
AU4645993A (en) * 1992-06-22 1994-01-24 New York University Mammalian growth factor
WO1994028889A1 (en) * 1993-06-08 1994-12-22 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
US6645945B1 (en) 1996-03-05 2003-11-11 Depuy Acromed, Inc. Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
AU729086C (en) * 1996-03-05 2006-12-14 Depuy Acromed, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US20110207666A1 (en) * 1996-03-05 2011-08-25 Depuy Spine, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
EP1071445A2 (en) * 1998-04-17 2001-01-31 Angiogenix, Incorporated Therapeutic angiogenic factors and methods for their use
US20030166550A1 (en) * 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US6451303B1 (en) 1998-10-13 2002-09-17 Chiron Corporation Method of treating coronary artery disease by administering a recombinant FGF
US20020072489A1 (en) * 1998-10-13 2002-06-13 Whitehouse Martha J. Angiogenically effective unit dose of FGF-2 and method of use
US6440934B1 (en) 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
EP1207900A2 (en) * 1999-08-13 2002-05-29 Chiron Corporation Dose of an angiogenic factor and method of administering to improve myocardial blood flow
AU2001278981A1 (en) * 2000-07-21 2002-02-05 Tom F Lue Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
CN102076352B (zh) * 2008-05-02 2016-06-15 西安大略大学 与血管有关的fgf-9和它的用途
TW201245221A (en) * 2011-05-02 2012-11-16 Baxter Int FGF based fibrin binding peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750197D1 (de) * 1986-04-22 1994-08-18 Salk Inst For Biological Studi Antagonisten des Fibroblasten-Wachstumsfaktors.
CA1323317C (en) * 1987-01-16 1993-10-19 Allen R. Banks Production of fibroblast growth factor
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
EP0298723A1 (en) * 1987-07-07 1989-01-11 California Biotechnology, Inc. Recombinant fibroblast growth factors
AU638402B2 (en) * 1987-11-24 1993-07-01 Amgen, Inc. Analogs of fibroblast growth factor
DE69119869T2 (de) * 1990-11-23 1996-12-12 American Cyanamid Co Chimeres Fibroblasten-Wachstumsfaktor
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production

Also Published As

Publication number Publication date
ZA919259B (en) 1992-08-26
IL99985A0 (en) 1992-08-18
NZ240623A (en) 1994-08-26
IE914067A1 (en) 1992-06-03
AU647547B2 (en) 1994-03-24
US5206354A (en) 1993-04-27
KR920009849A (ko) 1992-06-25
PT99566A (pt) 1992-10-30
CA2055961A1 (en) 1992-05-24
US5387673A (en) 1995-02-07
TW211585B (enExample) 1993-08-21
EP0486861A1 (en) 1992-05-27
AU8806491A (en) 1992-05-28

Similar Documents

Publication Publication Date Title
US5302702A (en) Chimeric fibroblast growth factors
US5206354A (en) Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
JP3385040B2 (ja) グリア活性化因子およびその製造法
Linemeyer et al. Disulfide bonds are neither required, present, nor compatible with full activity of human recombinant acidic fibroblast growth factor
US5223483A (en) Cysteine-modified acidic fibroblast growth factor
CA1340834C (en) Derivatives of human/bovine basic fibroblast growth factor
JP2829405B2 (ja) 機能性ポリペプチド
JP3923516B2 (ja) 生物学的に活性な二量体型タンパク質の製造のための新規の方法
IE62101B1 (en) Cloning and expression of acidic fibroblast growth factor
WO2001019868A1 (en) A novel angiogenesis inhibitor
EP0319052B1 (en) Mutant acidic fibroblast growth factor
JPH05271279A (ja) ヒト副甲状腺ホルモンムテインおよびその製造法
EP1506295B1 (en) Muteins of placental growth factor type 1, preparation method and application thereof
US5409897A (en) Cysteine-modified acidic fibroblast growth factor and methods of use
JP3943110B2 (ja) 血小板由来増殖因子アナログに結合する抗体
EP0535337A2 (en) Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor
Burgess Structure-Function Analysis of Fibroblast Growth Factor-1 (Acidic Fibroblast Growth Factor)